Dexamethasone-induced immunosuppression: mechanisms and implications for immunotherapy

Abstract Background Corticosteroids are routinely utilized to alleviate edema in patients with intracranial lesions and are first-line agents to combat immune-related adverse events (irAEs) that arise with immune checkpoint blockade treatment. However, it is not known if or when corticosteroids can...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Amber J. Giles, Marsha-Kay N. D. Hutchinson, Heather M. Sonnemann, Jinkyu Jung, Peter E. Fecci, Nivedita M. Ratnam, Wei Zhang, Hua Song, Rolanda Bailey, Dionne Davis, Caitlin M. Reid, Deric M. Park, Mark R. Gilbert
Materialtyp: Artigo
Språk:Inglês
Publicerad: BMJ Publishing Group 2018-06-01
Serie:Journal for ImmunoTherapy of Cancer
Ämnen:
Corticosteroids
Immunotherapy
Glioma
Checkpoint blockade
Dexamethasone
Länkar:http://link.springer.com/article/10.1186/s40425-018-0371-5
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk